ASCCT 14th Annual Meeting 📍 Gaithersburg, USA | 🗓 October 21–23, 2025 Meet us at this year's ASCCT annual meeting in Gaithersburg, where SenzaGen's scientific team will share new insights on quantitative skin sensitization potency assessment and present results from the pre-validation study of GARD®skin Medical Device. What to connect with us while you are […]
3rd Annual Medical Device Biocompatibility Conference Berlin, Germany | Nov 6-7 Come meet us at this year’s Medical Device Biocompatibility Conference in Berlin, where SenzaGen's chief scientist Henrik Johansson will present recent progress in applying New Approach Methodologies (NAMs) for skin sensitization testing within the ISO 10993 framework, including current regulatory developments and data from […]
Bringing high performance and extended applicability to Defined Approaches for Skin Sensitization (DASS) Join us for a special re-run of our popular webcast to learn more about the inclusion of GARD®skin in OECD TG 497 — what it means and how it can support your regulatory testing strategy. Defined Approaches for Skin Sensitization (DASS) is […]
NAMs for skin sensitization ISO 10993-10 Join us for an insightful webinar on the evolving role of New Approach Methodologies (NAMs) in biological safety testing of Medical Devices, with a special focus on skin sensitization – the area currently undergoing the most significant regulatory changes. As ISO standards advance toward reducing animal testing, understanding these […]
Booth #1934 San Diego, CA, USA Join our scientific sessions and poster presentations at this year's SOT, featuring the latest GARD® data and case studies generated in collaboration with industry leaders. Meet us at booth #1934 and discuss your specific testing needs with our scientific team - We help you design testing strategies tailored to […]
Scientific highlights from 2026 SOT Join us for an insightful webinar exploring the latest advancements in respiratory sensitization testing, an emerging field facing challenges in both scientific and regulatory landscapes. We will highlight how New Approach Methodologies (NAMs) are advancing human-relevant, non-animal strategies for respiratory hazard assessment. Together with guest speakers Dr. Emily Reinke (GDIT) […]
New GARD® data on Fragrances, Complex Mixtures, and Biopesticides Join us for the first webinar in a series focusing on in vitro skin sensitization potency assessment. In this opening session, we will address common challenges in potency testing and highlight new GARD® data generated through scientific collaborations with dōTERRA and Bayer, recently presented at the […]
Difficult-to-test samples: Natural Complex Substances and Cosmetic Formulations Join us for the second webinar in our series, further exploring the challenges and opportunities of New Approach Methodologies (NAMs) for in vitro skin sensitization potency testing, with a special focus on difficult-to-test substances. In this session, Dr Julie Anne Cote from The Honest Company, Dr Isabelle […]
Meet SenzaGen group companies VitroScreen and ToxHub at the 65th AFI Symposium, June 10-12, at the Palacongressi in Rimini. Meet SenzaGen Group at booth No. 5 At the event, VitroScreen and ToxHub will showcase how our combined scientific capabilities support pharma and medical device development through non-animal safety and efficacy testing approaches, and regulatory toxicology […]
Maastricht, the Netherlands “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs” Posters Tuesday, 30 June P23: #272 - "Adapting RNA-seq as an alternative acquisition platform for gene expression quantification in the GARDskin assay" p71: #269 - "In vitro sensitization assessment of medical device extracts: Prevalidation results of GARDskin Medical Device for potential inclusion […]
